Skip to content

Point of Care Early Infant Diagnosis Patient Impact Study

Evaluation of the Clinical Impact of Point-of-Care HIV Early Infant Diagnostic Technologies

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02744404
Enrollment
1752
Registered
2016-04-20
Start date
2015-09-30
Completion date
2016-09-30
Last updated
2018-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Brief summary

In Malawi, early infant HIV diagnosis (EID, i.e. HIV screening of infants under 18 months of age) is conducted using molecular diagnostics at central laboratories. However, test volumes are growing and many parts of the country do not have close or easy access to laboratories. Test samples are transported over large distances and this can introduce testing delays, especially for patients in rural and remote areas of the country. There are growing numbers of high quality Point-Of-Care (POC) diagnostic technologies available and there is increasing interest in using these technologies to alleviate critical testing needs. This protocol describes an observational study looking at the patient impact of implementing POC EID technologies within the routine standard of care at seven facilities.

Interventions

DEVICEPOC EID

Sponsors

Ministry of Health, Malawi
CollaboratorOTHER_GOV
UNICEF
CollaboratorOTHER
Clinton Health Access Initiative Inc.
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Months
Healthy volunteers
Yes

Inclusion criteria

* Younger than 12 months of age * Clinical or other indication for an EID test (screen or confirmation), such as birth to an HIV-positive mother

Exclusion criteria

* Older than 12 months of age * Serious medical conditions which would make testing dangerous for the infant, or disrupt the accuracy of normal laboratory analysis and its interpretation * Already initiated ART

Design outcomes

Primary

MeasureTime frameDescription
ART initiation retention6-9 monthsProportion of HIV-positive infants initiated on anti-retroviral therapy

Secondary

MeasureTime frameDescription
Test turnaround time6-9 monthsNumber of days from testing to result being received by the health care facility
Tests received6-9 monthsProportion of tests received by the health care facility

Countries

Malawi

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026